SciELO - Scientific Electronic Library Online

 
vol.24 issue3Pulmonary haemorrhage and primary antiphospholipid syndrome: case report and reviewPraneoplastic cerebellar degeneration as a presentation of breast cancer recurrence author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Anales de Medicina Interna

Print version ISSN 0212-7199

Abstract

PERAYRE BADIA, M.; LEIVA BADOSA, E.; PASTO CARDONA, L.  and  JODAR MASSANES, R.. Intermediate syndrome after organophosphate poisoning despite continuous infusion of pralidoxime. An. Med. Interna (Madrid) [online]. 2007, vol.24, n.3, pp.129-131. ISSN 0212-7199.

Acute organophosphate poisoning leads to a cholinergic crisis secondary to an acetylcholine rise, developed by an acetylcholinesterase inhibition. In some cases, after the resolution of the initial cholinergic signs and symptoms, an intermediate syndrome occurs, characterized by a delayed development of proximal and diaphragmatic muscle paralysis. We describe a case of a 67-year-old man who developed an intermediate syndrome after oxydemeton-metryl ingestion in a suicide attempt, despite a continuous pralidoxime infusion. Several hypotheses have been developed to explain the aetiology of this intermediate syndrome (neuromuscular junction dysfunction, inadequate poisoning treatment, late beginning of the oxime administration, etc). Intermediate syndrome manifestation will depend on the organophosphate's organism persistence and its chemical structure, and also on the time elapsed between the poisoning and the antidote administration.

Keywords : Organophosphates; Intermediate syndrome; Poisoning; Pralidoxime; Oxydemeton methyl.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License